Celiac disease in Turkey Aydan Kansu Zarife Kuloğlu Ankara University School of Medicine Pediatric Gastroenterology, Hepatology and Nutrition MEDICEL Meeting.

Slides:



Advertisements
Similar presentations
Recognition and assessment of coeliac disease Implementing NICE guidance 2009 NICE clinical guideline 86.
Advertisements

Celiac disease in Slovenia
The “Great Mimic” Disease
A.M. Report 5/5/09 Jason Haag, M.D.
Aydan Kansu, MD Ankara University School of Medicine, Department of Pediatric Gastroenterology and Hepatology, Turkey Field Study by the POINT-OF- CARE.
PRA = 36% (21/58) Anti-A11 and B44.
Report of the POCT Project Aydan Kansu – Turkey. Tokat Konya.
Definition. Celiac disease is an immune-mediated enteropathycaused by a permanent sensitivity to gluten in genetically susceptible individuals. It occurs.
Celiac disease Prepared by :Maha Hmeidan nahal.
Raanan Shamir, MD Cost Effectiveness of Population Screening
THE CELIAC PATIENT Carol E. Semrad, M.D. Associate Professor of Medicine The University of Chicago.
The prospective study and the new ESPGHAN protocol L. Greco, D. Mičetić-Turk Mediterranean Network for Celiac Disease Istanbul, June 30th 2012.
CD in Albania Albania: About: inhabitants 28000km2 surface Capital: Tirana.
Prof. Dr. Giuseppe Magazzu Prof. Dr. Dušanka Mičetić-Turk and all Progress of the Prospective study - Medicel.
Celiac Disease in Malta Thomas M Attard MD FAAP FACG.
UNIVERSITY CLINICAL CENTER TUZLA DEPARTMENT OF PEDIATRICS BOSNIA AND HERZEGOVINA Dr. SELMA TERZIĆ.
UNIVERSITY CLINICAL CENTER TUZLA DEPARTMENT OF PEDIATRICS BOSNIA AND HERZEGOVINA Dr. SELMA TERZIĆ, pediatrician.
…………. Aydan Kansu, MD Ankara University School of Medicine, Department of Pediatric Gastroenterology and Hepatology, Turkey.
SCREENING FOR CELIAC DISEASE IN EGYPTIAN CHILDREN SCREENING FOR CELIAC DISEASE IN EGYPTIAN CHILDREN Prof. Dr: Mona Abu Zekry -Professor of Pediatrics Head.
Dept. of 1 Public Health and Clinical Medicine, Epidemiology and Public Health Sciences, Umeå University; 2 Pediatrics, Lund University; 3 Pediatrics,
Celiac Disease in Children Dascha C. Weir, MD Boston Children’s Hospital Harvard Medical School Gluten Free for Life Conference April 11, 2015.
1 Serum Enzymes in Disease Dr. Essam H. Aljiffri.
The near future, applications and activities G. Magazzù and L. Greco.
Celiac Disease and Diabetes Marian Rewers, MD, PhD Professor & Clinical Director University of Colorado, School of Medicine.
Coeliac disease in Croatia Zrinjka Mišak Sanja Kolaček Referral Center for Paediatric Gastroenterology and Nutrition Children’s Hospital Zagreb, Croatia.
Celiac Disease (CD) Diagnosis and Whom to Screen Maureen Leonard MD Fellow, MassGeneral Hospital for Children.
UNIVERSITY CLINICAL CENTER TUZLA DEPARTMENT OF PEDIATRICS BOSNIA AND HERZEGOVINA Dr. SELMA TERZIĆ.
Celiac Disease in Primary Care Dustin M Adkins Spring 2007.
‘National Pictures of Celiac Disease ‘ GREECE Roma Eleftheria Professor of Paediatric Gastroenterology University of Athens Naples, September 2010.
The Mediterranean Network for the management of food induced diseases WORKSHOP MEDI-CEL The Mediterranean Network for Celiac Disease V Progress Meeting.
Zrinjka Mišak Referral Centre for Paediatric Gastroenteorology and Nutrition Children’s Hospital Zagreb Zagreb, Croatia Checking the quality of diagnostic.
Failure to Thrive in Toddler By: Celeste Schwartz, Melissa Rivera, Emily Foley, Yazmin Irazoqui-Ruiz.
4. Department of Psychiatry, Johns Hopkins School of Medicine
LFT Ordering Behavior Payam Parvinchiha DSR 2. Guidelines No guidelines for ordering of LFT Should not be a screening test for liver disease population-based.
THE IMPORTANCE OF DIAGNOSIS AND DIET THERAPY IN CELIAC DISEASE Author: Miklos Andreea Doriana Coordinator: Lecturer dr. Fárr Ana-Maria.
Ben Greenfield 28 September Epidemiology 1% of the population in North America More common in the Caucasian population, very rare in Asian and African.
Comparison of the diagnostic value of STA test and ELISA IgG and IgM in patients with Brucellosis Mustafa Ertek, Halil Yzgi, Zulal Ozkart et al. Turk.
1 Activation of Innate and not Adaptive Immune system in Gluten Sensitivity Update: Differential mucosal IL-17 expression in gluten sensitivity and the.
Comparison of the diagnostic value of STA test and ELISA IgG and IgM in patients with Brucellosis Mustafa Ertek, Halil Yzgi, Zulal Ozkart et al. Turk J.
Screening for Celiac Disease In Rural Areas in Egypt Prof. Dr: Mona Abu Zekry Cairo University.
Prof. Dr. Giuseppe Magazzu Prof. Dr. Dušanka Mičetić-Turk and all Progress of the Prospective study - Medicel.
The Sicilian Step Forward on Celiac Disease MEDICEL Meeting Palermo, 2014 April 26 th.
Celiac Disease.
CELIAC DISEASE. ESPGHAN 2012 : Guidelines for the Diagnosis in Children & Adolescents Definition: “CD is an immune-mediated systemic disorder elicited.
The First MEDICEL Meeting Cairo 30 th April to 1 st May 30 th April to 1 st May Prof. Luigi Greco Dr. Laura Timpone Following ESPGHAN PROTOCOL REVISION.
Celiac Disease Gluten Sensitive Enteropathy. Celiac Disease: Immune mediated enteropathy caused by permanent sensitivity to gluten in genetically susceptible.
Coeliac Disease. What is Coeliac disease? Autoimmune Heightened immunological response to ingested GLUTEN In genetically susceptible people.
ESPGHAN COMMITTEE to revise the diagnostic protocol of Celiac Disease Prof. Riccardo Troncone, President March 2010.
Diagnosis and Treatment of Celiac Disease in Children
Nutritional management paediatric CKD Dr. CKD – Chronic kidney disease.
Celiac Disease Equipping primary care physicians to manage most patients Eric Poulin, MD First Light Health System Mora, Minnesota.
POCT FOR DIAGNOSIS OF CELIAC DISEASE IN EGYPTIAN CHILDREN Prof Dr Mona Ahmed Abu Zekry Professor of Pediatrics and Pediatric Gastroenterology Children.
Charles P.B. Vanderpool, MD Assistant Professor of Clinical Pediatrics
Presented by: Dallas Montag Date: 12/6/16
Tissue Transglutaminase IgA and IgG Correlation with Histology and their Role in a ‘Celiac Panel’; an Institutional Experience Shana Godfred-Cato, DO,
Relationship between CMV & PU disease
Volume 136, Issue 3, Pages (March 2009)
Basics of PSC Christopher L. Bowlus, MD
Associated Conditions
Volume 136, Issue 3, Pages (March 2009)
The prospective study and the new ESPGHAN protocol
What Is the Role of Serologic Testing in Celiac Disease
Figure 1 Suggested biopsy-avoiding diagnostic pathway for coeliac disease Figure 1 | Suggested biopsy-avoiding diagnostic pathway for coeliac disease.
Gliadin Does Not Induce Mucosal Inflammation or Basophil Activation in Patients With Nonceliac Gluten Sensitivity  Cristina Bucci, Fabiana Zingone, Ilaria.
Identification of Pediatric Patients With Celiac Disease Based on Serology and a Classification and Regression Tree Analysis  Anna Ermarth, Matthew Bryce,
Volume 136, Issue 3, Pages (March 2009)
Factors That Contribute to Hypertransaminasemia in Patients With Celiac Disease or Functional Gastrointestinal Syndromes  Barbara Zanini, Roberta Baschè,
Type 1 DM and Coeliac Disease Quality Standards Audit
Risk of Pancreatitis in Patients With Celiac Disease: Is Autoimmune Pancreatitis a Biologically Plausible Mechanism?  John S. Leeds, David S. Sanders 
Table 1. Clinical symptoms in MAS and recommended laboratory tests
Presentation transcript:

Celiac disease in Turkey Aydan Kansu Zarife Kuloğlu Ankara University School of Medicine Pediatric Gastroenterology, Hepatology and Nutrition MEDICEL Meeting Naples September

Turkey Population: year: Estimated CD (children): TPGHAN (about 100 members) Pediatric Gastroenterology Departments:30 Celiac society  Ankara  İstanbul  İzmir  Diyarbakır

Epidemiology Ertekin V. J Clin Gastroenterol 2005;8:  6-17 y, 1263, ttg IgA Seropositivity.1/115 Biopsy proven CD:1/158 Demirçeken F. Turk J Gastroenterol 2008;19:14-21  2-18 y, 1000, ttg IgA Seropositivity.1/100 Biopsy proven CD:1/111

Epidemiology Dalgıç B and Turkish Celiac Disease Study Group. ESPGHAN 2010, İstanbul  6-17 y, Two-stratified Cluster sampling, 20190, 62 cities ttG IgA, ttg IgG, EMA Ig A, same pathologist

Epidemiology

Prevalance:1/212 (0.47%)

HLA types Tüysüz B. Tissue Antigens 2001;6:540-2  55 CD&50 control HLA DQA1, DQB1 (PCR –SSP) HLA A10501, HLA DQB102 alles in  than control Kuloğlu Z, Turk J Pediatr 2008;50:  75 CD (45 classic form: 6.7±3.8 y&30 atypical 9.3±4.3y)  100 healthy renal Tx donors HLA typing: Serologically (standart lymphotoxicity techniques) Control group: HLA A29, B51, CW5, DR14, Dr16, DQ1  CD: HLA B13, CW7, B8, DR7, DR17, DQ2 was higher than control HLAB35, DR11, DQ7:classical type HLA B8: Atypical type

Clinical Presentation 109 patients, 8.8±4.6 y  60.6% Classical type  37.6% atypical  1.8% silent Sx: Diarrhea (53.2%), FTT, short stature, abdominal pain PE: paleness (40.4%), underweight (34.8%), short stature (31.2%) Lab  IDA (81.6%), zinc def (64.1%), PT  (35.8%), transaminase  (24.7%)  Ig A deficiency (9.1%), ab (+) (8%), BMD  (28/52), EEG abnormality (4/38)  HLA DQ2 and/orDQ8:91% Abdominal distention, IDA, PT , hypoalbuminemia, transaminase  more frequent in classical type than atypical form

Clinical Presentation Altuntaş B. Acta Pediatr Jpn 1998;40:  47 short statured patients (without GIS symptoms)  Bx proven CD:55% Altuntaş B. Acta Pediatr Jpn 1998;40:597-9  9 patients, ALT   Liver Bx: fibrosis, nonspecific reaction  Duodenal Bx: CD

Clinical Presentation 32 CD (16 recent diagnosis&16 GFD) 100 healthy control  BMD, Ca, P, ALP, PTH (baseline&12 mo) Dual energy radiograph bone densitometer, L1-4, g/cm 2 BMD& BMC were lower in CD than control Osteoporosis was common in recent diagnosis 1 year later BMD values in patients with recent diagnosis significantly increased After 1 year osteopenia was resolved

Clinical Presentation 50 with FMF ( questioned, examined, IgA, AGA IgA, AGA IgG, EMA IgA, bx)  1 EMA (+), bx normal 17 with CD (questioned, examined, lab, mutation analysis for MEFV)  MEFV mutation:23.5% No assosication between CD and FMF

Clinical Presentation Sarı S. Dig Dis Sci 2009;54:830-2  101 autoimmune thyroiditis  103 healthy  Bx proven CD:4.9% Dalgıç B. J Child Neurol 2008;21:6-7  70 epilepsy&103 control  Bx proven CD: 1.8% Alehan F. Cephalalgia 2009;28:945-9  73 migraine&147 control  Bx proven CD:- Kalaycı AG. Acta Paediatr 2005;8:  135 IDA &223 control  Biopsy proven CD:4.4%

Clinical Presentation Selimoğlu MA. J Clin Gastroenterol 2007;7:  126 CD  AST  (51.6%), ALT  (35.7%), CK  (39.7)  Myopathy? Polat TB. Dig Liver Dis 2008;  45 CD&30 control  Subclinical systolic dysfunction of the left ventricule

Follow-up Aydoğdu S. Dig Dis Sci 2009;10:  34 CD, followed for at least four years GFD leads to rapid increase in W SDS and H SDS in patients < 5 y Increase in H SDS is highest in patients 5-10 y Age at diagnosis is the major factor for W SDS and H SDS at follow-up  Early diagnosis and strict GFD are essential for long- term growth

Leptin&Ghrelin&Nitric oxide Ertekin V. J Clin Gastroenterol 2006;10:906-9  19 CD&16 control  Serum leptin level is affected in CD, is not related to histopathology, is responsive to GFD Selimoğlu MA. JClin Gastroenterol 2006;3:191-4  36 CD&10 healthy  Ghrelin is increased in CD and is responsive to GFD Ertekin V. J Clin Gastroenterol 2005;39:  41 CD&14 control  NO level is high in CD non adharent to GFD

Conclusion CD is common in Turkey CD is a well known disease among pediatric gastroenterologists Rising awareness is needed among pediatricians and in primary care and also among society Serologic diagnostic tools are needed to be available routinely Wheat is basic nutrient in Turkish cousine, therefore adherance to GFD may be difficult GFD products are not widely accessible Financial support of the state for GFD is not enough